Wikidata

(Q65332341)

English

Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer

clinical trial

In more languages

Statements

short name
KESTREL (English)
0 references
title
A Phase III Randomized, Open-label, Multi-center, Global Study of MEDI4736 Alone or in Combination With Tremelimumab Versus Standard of Care in the Treatment of First-line Recurrent or Metastatic Squamous Cell Head and Neck Cancer Patients (English)
0 references
country
Austria
0 references
Belgium
0 references
Brazil
0 references
Canada
0 references
France
0 references
Germany
0 references
Greece
0 references
India
0 references
Italy
0 references
Japan
0 references
Philippines
0 references
Poland
0 references
Romania
0 references
Slovakia
0 references
Spain
0 references
Taiwan
0 references
Thailand
0 references
Ukraine
0 references
United Kingdom
0 references
Vietnam
0 references
start time
15 October 2015
0 references
end time
30 September 2019
0 references
number of participants
823
0 references
research intervention
carboplatin
0 references
fluorouracil
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65332341&oldid=1858143579"